Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | RAD52 | P43351 | 1/20 | 0.55 |
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | HTR2C | P28335 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17891954 | 1.00 | NAAA (0.64) | NAAANPSR1RAD52DGKAFAAH | |
| SCHEMBL1867284 | 1.00 | NAAA (0.64) | NAAANPSR1RAD52DGKAFAAH | |
| SCHEMBL573930 | 1.00 | NAAA (0.64) | NAAANPSR1RAD52DGKAFAAH | |
| SCHEMBL17891961 | 1.00 | NAAA (0.64) | NAAANPSR1RAD52DGKAFAAH | |
| SCHEMBL27919918 | 1.00 | NAAA (0.64) | NAAANPSR1RAD52DGKAFAAH | |
| SCHEMBL17891951 | 1.00 | NAAA (0.64) | NAAANPSR1RAD52DGKAFAAH | |
| SCHEMBL3504225 | 1.00 | NAAA (0.64) | NAAANPSR1RAD52DGKAFAAH | |
| SCHEMBL17891959 | 1.00 | NAAA (0.64) | NAAANPSR1RAD52DGKAFAAH | |
| SCHEMBL4316279 | 1.00 | NAAA (0.64) | NAAANPSR1RAD52DGKAFAAH | |
| Ammonia Solution, Strong SCHEMBL9109978 | 0.98 | NAAA (0.62) | NAAANPSR1RAD52DGKAFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 220 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| CN-115501171-A | High-concentration azelaic acid emulsifiable paste and preparation process thereof | 上海丽舒丹医药科技有限公司 | 2022-12-23 | — | — | CN | claimed |
| CN-113406251-B | Method for predicting storage years of white spirit | 江南大学 | 2022-05-17 | — | — | CN | claimed |
| CN-113406251-A | Method for predicting storage years of white spirit | 江南大学 | 2021-09-17 | — | — | CN | claimed |
| EP-3809876-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2021-04-28 | — | — | EP | claimed |
| WO-2019243869-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2019-12-26 | — | — | WO | claimed |
| WO-2018053344-A1 | SWEETNESS ENHANCING VOLATILE COMPOSITIONS AND METHODS OF INCREASING PERCEIVED SWEETNESS OF A COMESTIBLE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2018-03-22 | — | — | WO | claimed |
| US-20170119034-A1 | COMPOSITIONS AND METHODS FOR MODIFYING PERCEPTION OF SWEET TASTE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2017-05-04 | — | — | US | claimed |
| US-9480649-B2 | Lipid microparticle growth factor formulations | BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA MBH (DE) | 2016-11-01 | — | — | US | claimed |
| WO-2013163272-A1 | COMPOSITIONS AND METHODS FOR MODIFYING PERCEPTION OF SWEET TASTE | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2013-10-31 | — | — | WO | claimed |
| EP-1697386-B1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GEN ELECTRIC (US) | 2007-10-10 | — | — | EP | claimed |
| CN-1893910-A | Cyclic siloxane compositions for active ingredient release | GEN ELECTRIC (US) | 2007-01-10 | — | — | CN | claimed |
| EP-1716159-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | General Electronic Company (US) | 2006-11-02 | — | — | EP | claimed |
| EP-1697386-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | General Electric Company A Corporation of the State of New York (US) | 2006-09-06 | — | — | EP | claimed |
| US-6991785-B2 | Method for administering a cytokine to the central nervous system and the lymphatic system | CHIRON CORPORATION (US) | 2006-01-31 | — | — | US | claimed |
| WO-2005066187-A1 | ACTIVE INGREDIENT-RELEASING CYCLIC SILOXANES | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| WO-2005066186-A2 | CYCLIC SILOXANE COMPOSITIONS FOR THE RELEASE OF ACTIVE INGREDIENTS | GENERAL ELECTRIC COMPANY (US) | 2005-07-21 | — | — | WO | claimed |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-06-23 | — | — | US | claimed |
| US-5993778-A | RECEPTORS IN NEURONAL CELLS, INCLUDING METHODS FOR DETECTING PARTICULAR ODORANT LIGAND SPECIFICITY FOR PARTICULAR ODORANT RECEPTORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 1999-11-30 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050136022-A1 | Cyclic siloxane compositions for the release of active ingredients | F9, RPL39, ECPAS | NAAA 3140/4885NPSR1 2307/4885RAD52 3097/4885 |
| US-20050136021-A1 | Active-releasing cyclic siloxanes | F9, RPL39, ALDH16A1 | NAAA 2357/4885NPSR1 1287/4885RAD52 2953/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.